Dashboard
Manage Tickers

RENB Enochian Biosciences Inc

Nasdaq enochianbio.com


$ 1.20 $ -0.02 (-1.64 %)    

Friday, 17-Oct-2025 15:59:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.2
$ 1.22
$ 1.15 x 201
$ 1.39 x 2,500
$ 1.15 - $ 1.27
$ 0.12 - $ 2.10
166,981
na
27.82M
$ 0.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-29-2025 06-30-2025 10-K
2 05-15-2025 03-31-2025 10-Q
3 02-19-2025 12-31-2024 10-Q
4 11-14-2024 09-30-2024 10-Q
5 10-10-2024 06-30-2024 10-K
6 05-15-2024 03-31-2024 10-Q
7 02-14-2024 12-31-2023 10-Q
8 11-14-2023 09-30-2023 10-Q
9 10-02-2023 06-30-2023 10-K
10 05-12-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-Q
12 03-07-2023 09-30-2022 10-Q
13 02-27-2023 06-30-2022 10-K
14 05-12-2022 03-31-2022 10-Q
15 02-14-2022 12-31-2021 10-Q
16 11-15-2021 09-30-2021 10-Q
17 09-24-2021 06-30-2021 10-K
18 05-17-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-Q
20 11-12-2020 09-30-2020 10-Q
21 09-23-2020 06-30-2020 10-K
22 05-11-2020 03-31-2020 10-Q
23 02-10-2020 12-31-2019 10-Q
24 11-13-2019 09-30-2019 10-Q
25 09-30-2019 06-30-2019 10-K
26 05-16-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-Q
28 11-14-2018 09-30-2018 10-Q
29 10-01-2018 06-30-2018 10-K
30 05-15-2018 03-31-2018 10-Q
31 02-09-2018 12-31-2017 10-Q
32 11-20-2017 09-30-2017 10-Q
33 09-29-2017 06-30-2017 10-K
34 05-15-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-Q
36 11-14-2016 09-30-2016 10-Q
37 09-28-2016 06-30-2016 10-K
38 05-13-2016 03-31-2016 10-Q
39 02-12-2016 12-31-2015 10-Q
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Lunai Bioworks Adopts New Corporate Identi...
09/30/2025 13:43:43

Lunai Bioworks Inc. (NASDAQ:LNAI), a pioneer in AI-powered drug discovery and biodefense, today announced the formal adoption o...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/30/2025 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/29/2025 23:50:04

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 17:06:09

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 12:08:49

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket
Why PepGen Shares Are Trading Higher By 11...
09/25/2025 10:11:08

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

lunai-bioworks-announces-10-for-1-reverse-stock-split-effective-september-30-2025
Lunai Bioworks Announces 10-For-1 Reverse ...
09/24/2025 20:51:41

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid PriceLOS ANGELES, CA / ACCESS Newswire / September 24...

lunai-bioworks-subsidiary-biosymetrics-wins-185m-nih-grant-to-advance-ai-powered-alcohol-use-disorder-drug-discovery
Lunai Bioworks Subsidiary BioSymetrics Win...
09/11/2025 11:07:23

Lunai Bioworks Inc.'s (NASDAQ:RENB) wholly-owned subsidiary BioSymetrics Inc. today announced the award of a prestigious Sm...

top-3-health-care-stocks-youll-regret-missing-in-q3
Top 3 Health Care Stocks You'll Regret Mis...
09/09/2025 13:12:17

lunai-bioworks-launches-ai-platform-embedding-biological-risk-intelligence-to-accelerate-drug-discovery-and-enhance-biodefense-against-ai-designed-toxins
Lunai Bioworks Launches AI Platform Embedd...
09/09/2025 12:48:45

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense.LOS ANGELES, CALIFORNIA / ACC...

lunai-bioworks-reaffirms-long-term-commitment-to-european-markets-and-partnerships-amid-bankruptcy-of-subsidiary-gedi-cube
Lunai Bioworks Reaffirms Long-Term Commitm...
09/08/2025 12:53:02

unai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery and biodefense company, today reaffirmed its long-term commitmen...

lunai-bioworks-dba-renovaro-partners-with-american-defense-international-to-advance-ai-powered-countermeasures-against-chemical-and-biological-threats-including-highly-toxic-agents-such-as-sarin-nerve-gas
Lunai Bioworks DBA Renovaro Partners With ...
09/04/2025 14:09:48

Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical ag...

renovaro-to-change-its-corporate-name-to-lunai-bioworks-inc-reflecting-strategic-direction-in-ai-powered-biodefense-drug-discovery-and-advanced-diagnostics
Renovaro To Change Its Corporate Name To L...
08/27/2025 13:47:47

Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect it...

renovaro-multiple-us-patent-allowances-to-bolster-biomedical-ai-platform-including-application-no-18058732-for-unbiased-drug-discovery-predictions
Renovaro Multiple U.S. Patent Allowances T...
07/28/2025 14:41:28

Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and precisi...

renovaros-maurice-van-tilburg-resigns-as-chairman-of-the-board-of-directors-effective-august-22-2025
Renovaro's Maurice Van Tilburg Resigns As ...
07/25/2025 21:22:11

-SEC Filing

renovaro-biosciences-announces-publication-of-peer-reviewed-study-in-vaccines-says-preclinical-data-validate-renovaros-platform-representing-step-forward-in-fight-against-pancreatic-and-solid-tumors
Renovaro Biosciences Announces Publication...
07/17/2025 13:20:34

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and soli...

renovaro-says-senior-debt-holders-agreed-to-convert-97m-of-outstanding-senior-debt-into-convertible-debt-which-they-have-elected-to-convert-to-equity
Renovaro Says Senior Debt Holders Agreed T...
07/09/2025 12:04:19

renovaros-biosymetrics-unveils-proprietary-ai-based-zebrafish-screening-platform-to-identify-medical-countermeasures-for-neurotoxic-chemical-agents
Renovaro's BioSymetrics Unveils Proprietar...
06/30/2025 13:30:58

Renovaro Inc.'s (NASDAQ:RENB) wholly owned subsidiary BioSymetrics has unveiled a proprietary AI-based zebrafish screening ...

renovaro-subsidiary-biosymetrics-secures-uspto-patent-allowance-for-ai--powered-drug-discovery
Renovaro Subsidiary BioSymetrics Secures U...
06/03/2025 13:17:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION